Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010114 · ClinicalTrials.gov registry record
Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children
A clinical trial, sponsored by Pediatric Brain Tumor Consortium.
- Completed
- Registry status
- 83
- Enrollment target
NCT00010114: Completed study, sponsored by Pediatric Brain Tumor Consortium.
NCT00010114 is a clinical trial that has completed, run by Pediatric Brain Tumor Consortium. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00010114 has completed, sponsored by Pediatric Brain Tumor Consortium.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. PURPOSE: Genetic study to learn more about genes involved in the development of central nervous system tumors in young children.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2001-03 |
| Est. Completion | 2003-03 |
What the finished NCT00010114 record still lists
NCT00010114 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00010114 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00010114 about?
NCT00010114 is a clinical study titled "Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children". RATIONALE: Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer. PURPOSE: Genetic study to learn more about genes involved in the development of central nervous system tumors in young children.
What is the current status of trial NCT00010114?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2001-03. Estimated completion is 2003-03.
Who is sponsoring clinical trial NCT00010114?
This trial is sponsored by Pediatric Brain Tumor Consortium, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia